Riva, C., Minetto, P., Zecchetti, G., Nicoletta, S., Azzanelli, Y., Romei, R., Colombo, N., Parodi, A., Tedone, E., Carminati, E., Puglisi, F., Nurra, C., Fugazza, G., Nozza, P., Cea, M., Lemoli, R., Guolo, F. (2025). Molecular profile linked to resistance to hypomethilating agents plus venetoclax does not predict outcome in secondary Acute Myeloid Leukemia patients receiving CPX-351 induction.. Blood. https://doi.org/10.1182/blood-2025-3402